Compare PHUN & UG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PHUN | UG |
|---|---|---|
| Founded | 2009 | 1942 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Package Goods/Cosmetics |
| Sector | Technology | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.1M | 30.2M |
| IPO Year | 2016 | 1995 |
| Metric | PHUN | UG |
|---|---|---|
| Price | $1.72 | $6.54 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $7.25 | N/A |
| AVG Volume (30 Days) | ★ 91.8K | 3.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.69% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.20 |
| Revenue | ★ $30,883,000.00 | $12,181,971.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $95.95 | N/A |
| P/E Ratio | ★ N/A | $33.40 |
| Revenue Growth | ★ 15.57 | 11.91 |
| 52 Week Low | $1.56 | $5.58 |
| 52 Week High | $3.88 | $10.09 |
| Indicator | PHUN | UG |
|---|---|---|
| Relative Strength Index (RSI) | 47.04 | 47.28 |
| Support Level | $1.60 | $6.31 |
| Resistance Level | $2.04 | $6.75 |
| Average True Range (ATR) | 0.08 | 0.17 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 52.05 | 41.54 |
Phunware Inc is a software company. It is a cloud platform for mobile that provides companies with the products, solutions, and data and services necessary to engage, manage and monetize its mobile application audiences. It derives maximum revenue from United States. The company has two reportable segments: Software subscriptions and services; and Advertising. It derives maximum revenue from Software subscriptions and services.
United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.